Catalyst Pharmaceutical Partners shares owned by UBS Group
Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Catalyst Pharmaceutical Partners
Tip: Access up to 7 years of quarterly data
All positions including Catalyst Pharmaceutical Partners held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Catalyst Pharmaceutical Partners by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $12M | 594k | 19.70 |
| 2025-06-30 | $18M | 845k | 21.70 |
| 2025-03-31 | $18M | 759k | 24.25 |
| 2024-12-31 | $15M | 723k | 20.87 |
| 2024-09-30 | $4.2M | 213k | 19.88 |
| 2024-06-30 | $2.6M | 169k | 15.49 |
| 2024-03-31 | $6.2M | 389k | 15.94 |
| 2023-12-31 | $7.9M | 469k | 16.81 |
| 2023-09-30 | $4.0M | 341k | 11.69 |
| 2023-06-30 | $4.8M | 358k | 13.44 |
| 2023-03-31 | $6.4M | 388k | 16.58 |
| 2022-12-31 | $11M | 590k | 18.60 |
| 2022-09-30 | $4.2M | 329k | 12.75 |
| 2022-06-30 | $2.3M | 325k | 7.01 |
| 2022-03-31 | $2.6M | 315k | 8.29 |
| 2021-12-31 | $2.0M | 290k | 6.77 |
| 2021-09-30 | $2.3M | 443k | 5.30 |
| 2021-06-30 | $2.3M | 397k | 5.71 |
| 2021-03-31 | $2.6M | 559k | 4.61 |
| 2020-12-31 | $1.1M | 330k | 3.34 |
| 2020-09-30 | $819k | 276k | 2.97 |
| 2020-03-31 | $9.0k | 2.3k | 3.96 |
| 2019-12-31 | $67k | 18k | 3.70 |
| 2019-09-30 | $1.2M | 227k | 5.31 |
| 2019-06-30 | $85k | 22k | 3.82 |
| 2018-12-31 | $69k | 36k | 1.93 |
| 2018-09-30 | $88k | 23k | 3.78 |
| 2018-06-30 | $38k | 12k | 3.12 |
| 2017-12-31 | $42k | 11k | 3.92 |
| 2017-09-30 | $6.0k | 2.4k | 2.50 |
| 2017-06-30 | $17k | 6.0k | 2.81 |
| 2016-06-30 | $38k | 54k | 0.71 |
| 2015-03-31 | $2.0k | 500 | 4.00 |
Top funds holding Catalyst Pharmaceutical Partners
View all funds holding Catalyst Pharmaceutical Partners